Biochem - E3 Flashcards

1
Q

2 Classes of lipids

A
  1. Fatty acid based
    - Amphipathic, micelle forming, soaps
    - Energy storage (fat deposits cushion organs & insulate against heat loss)
    - Membranes (electrical insulation of nerves), including phospholipids & sphingolipids
    - Signals.
  2. Isoprenoids
    - Bile Acids/Salts
    - Membranes,
    - Signals,
    - Cofactors,
    - Fat soluble vitamins.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

At neutral pH, fatty acids are ____ and act as _____

A

Charged, soaps.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Features of short chain FAs (<6)

A
  • Produced in colon by microbiome
  • Can cross blood brain barrier
  • 6-10% of total energy (80% in coloncytes)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Medium chain FAs (6-12) can be used as tx for…

A

Waldmann disease, epilepsy, chronic pancreatitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Long chain FAs (>12)

A

Are absorbed in the small intestine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Excess carbohydrate is converted into _____ (default) or _______ (regulated) by the liver.

A

Excess carbohydrate is converted into FAs (default) or cholesterol (regulated) by the liver.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

FAs and cholesterol are packaged into VLDL (___________) by ________& ________.

A

FAs & CHL are packaged into Very Low Density Lipoprotein (VLDL) via TAG synthase and acyl cholesterol acyl transferase (ACAT).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the characteristic apoprotein of VLDL?

A

Apoprotein of VLDL is Apo-B100 (formed from the same gene as B48).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

After release, the ApoCII of VLDL stimulates _____________ to hydrolyze FAs for storage in ______.

A

After release, the ApoCII of VLDL stimulates lipoprotein lipase (LPL) to hydrolyze FAs for storage in adipose.

(The LPL enzyme projects into the lumen of capillaries in many tissues - mostly adipose tissue, muscle, and some breast tissue)

  • LPL is the same enzyme that works on chylomicrons
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What generates Intermediate Density Lipoprotein (IDL)?

A

When TAGs = Cholesterol esters (CEs), ApoC-II falls off of VLDL and forms IDL.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

All cells need cholesterol to modulate ___________________.

_______ is the major serum transporter for cholesterol.

A

All cells need cholesterol to modulate membrane fluidity.

LDL is the major serum transporter for cholesterol.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How is LDL generated?

A

The liver expresses Hepatic Triglycerol Lipase (HTGL) to remove remaining TAGs from IDL to make LDL, the major transporter of cholesterol to tissues.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Does VLDL or LDL have longer half-life?

A

VLDL has a half-life of about 3 hours while LDL has a half-life of days.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the danger of LDL circulating for too long?

A

If LDL circulates too long, it gets oxidized, stimulates monocyte recruitment into the blood vessel wall.

Monocytes differentiate to macrophages and take up ox-LDL (via scavenger receptors).

If they take up too much –> become foam cells and die.

Dead foam cells (fatty streak), + smooth muscle cell growth (via signals from foam cells) + matrix degradation forms an atherosclerotic plaque.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

A function of HDL is the promotion of cholesterol efflux from cells… why is this so useful?

A

Efflux of cholesterol from foam cells –> reduction in foam cell formation; macrophages may accumulate, but are not converted into foam cells.

Inflammatory process is arrested to a certain extent.

So, HDL is anti-inflammatory and also protects against the development of atherosclerosis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

HDL is released as an “empty shell” by the liver intestine. It is released with ____________ & __________, ____________ (its characteristic apoproteins). CE’s get picked up later.

A

HDL is released with phospholipids & ApoA-I, ApoA-II (its characteristic apoproteins). CE’s get picked up later.

17
Q

Where does liver get cholesterol: synthesis, ________ ___________, mature HDL, LDL, ____________ (aka IDL).
As known as the “_____________________” pathway

A

Where does liver get cholesterol: synthesis, chylomicron remnants, mature HDL, LDL, VLDL remnants (aka IDL).
As known as the “reverse cholesterol transport” pathway

18
Q

What is the role of Lecithin Cholesterol Acyl Transferase (LCAT) as HDL travels through the blood and encounters cells with excess cholesterol on their surfaces?

A

Lecithin Cholesterol Acyl Transferase (LCAT) is stimulated by ApoA-1 and transfers CHL from cell to HDL.

LCAT removes a fatty acid from a membrane phospholipid to form CEs out of the excess cholesterol that has been moved to the cell surface. The lysolecithin that is produced can be repaired .

19
Q

What is the fate of HDL full of CEs?

A

They can be bound by Scavenger Receptor-BI (SRB1 or HDL receptor) on liver & adrenals for endocytosis & degradation.

20
Q

What does a 30% increase in LDL lead to?

What about a low LDL:HDL (1.5:1 rather than 3:1)?

A

30% increase in LDL = 3x risk of coronary mortality

A low LDL:HDL (1.5:1 rather than 3:1) halves risk of CHD.

Cholesterol is the same in LDL and in HDL: just packaged differently

21
Q

Describe the composition of chylomicrons.

A

Lipids (mostly TAG)&raquo_space; protein: low density

22
Q

Describe the composition of HDL

A

Lipids (mostly CEs) &laquo_space;protein: high density

23
Q

Arrange the post absorptive lipoproteins in order of TAG content from MOST to LEAST.

A

Most TAG –> Least TAG

Chylomicron, VLDL, IDL, LDL

24
Q

Describe Familial Hypercholesterolemia

A

Defective receptor for receiving LDL (LDL-R defect leads to greatly elevated LDL).

25
Q

Excess dietary carbohydrate become _______ and ________, packaged into VLDL

A

Excess dietary carbohydrate becomes Fatty Acids and cholesterol, packaged into VLDL

26
Q

Apo-C-II stimulate ___________________ to hydrolyze TAG from VLDL. VLDL loses ApoC-II, generating ___

A

Apo-C-II stimulates lipoprotein lipase (LPL) to hydrolyze TAG from VLDL

VLDL loses ApoC-II, generating IDL

27
Q

_______________________ removes TAGs of IDL to make LDL

A

Hepatic Triglycerol Lipase (HTGL) removes TAGs of IDL to make LDL

28
Q

____ is released with phospholipids & ApoA-I, ApoA-II and Apo’s C & E

Apo’s _____ are passed to VLDL & chylomicrons
_____ Activates LCAT to form CEs out of excess cholesterol

A

HDL is released with phospholipids & ApoA-I, ApoA-II and Apo’s C & E

Apo’s C (& E) are passed to VLDL & chylomicrons
ApoA-I Activates LCAT to form CEs out of excess cholesterol

29
Q

Mature HDL is bound by ________________

A

SR-BI receptors

30
Q

FAs are released from adipose cells when _________ activates ___________________- to phosphorylate and activate Hormone Sensitive _______ in adipose cells.

A

FAs are released from adipose cells when glucagon activates cAMP-dependent protein kinase to phosphorylate and activate Hormone Sensitive Lipase in adipose cells.

31
Q

FAs are carried by _________________, and activated inside cells that want to use them for energy by _______________.

(as for TAG formation in intestine) of Beta oxidation

A

FAs are carried by serum albumin, and activated inside cells that want to use them for energy by acyl-CoA synthetase.

32
Q

Long chain FAs are transferred to carnitine by ____________________ (CPT I, aka CAT I), and transferred into the ______________ by _____________________ (in exchange for carnitine coming out).

CPT II remakes acyl-CoA in the ______.
CPT I is inhibited by ______________, the first product in fatty acid synthesis.

A

Long chain FAs are transferred to carnitine by Carnitine Palmitoyl Transferase I (CPT I, aka CAT I), and transferred into the mitochondrial matrix by Carnitine:Acylcarnitine Translocase (in exchange for carnitine coming out).

CPT II remakes acyl-CoA in the matrix. CPT I is inhibited by malonyl-CoA, the first product in fatty acid synthesis.

33
Q

FA oxidation proceeds via a _________ specific for the length of the FA.

2-3 Enoyl CoA Hydratase, 3-OH-acylCoA-dehydrogenase, & 3-keto acylCoA thiolase will catalyze ____________________ & produce ______ and ______ & _______.

A

FA oxidation proceeds via a dehydrogenase specific for the length of the FA.

2-3 Enoyl CoA Hydratase, 3-OH-acylCoA-dehydrogenase, & 3-keto acylCoA thiolase will catalyze shortening of the fatty acid by 2 carbons & produce acetyl-CoA and FADH2 & NADH.

34
Q

Every time FA is shortened by 2C –> gen ________ (can make ___ ATP) and some NADH/FADH to make more ATP.

A

Every time FA is shortened by 2C –> gen acetyl-CoA (can make 12 ATP) and some NADH/FADH to make more ATP.

35
Q

The energy yield for FA oxidation is ______ per gram than that of glucose

A

The energy yield for FA oxidation is higher per gram than that of glucose.

36
Q

The cis 2-3 trans double bond situation (in beta oxidation) is resolved by a couple enzymes…

A

2,4 dienoyl-CoA reductase reducing one double bond & enoyl CoA isomerase.

37
Q

Oxidation of the alpha (alpha oxidation) carbon occurs in the ________ and is used to deal with the ______________ on _________ originally derived from plants.

Alpha carbon oxidation of phytanic acids is followed by beta oxidation to yield ________.

A

Alpha oxidation occurs in the peroxisomes and is used to deal with the methyl branch on phytanic acids originally derived from plants.

Alpha carbon oxidation of phytanic acids is followed by beta oxidation to yield propionyl CoA.

38
Q

Genetic deficiency in alpha-oxidation can lead to…

A

Neurological disorder (Refsum’s disease)

39
Q

FA disorders (FAOs)

A

Autosomal recessive metabolic disorders, enzymes necessary for fatty acid breakdown are unavailable or have reduced activity

Exp. hepatic failure, encephalopathy, heart and eye complications. General problems with muscle development.